scholarly journals An evaluation of the use of the Statewide Planning and Research Cooperative System of New York State as a resource planning tool for HIV infection.

1991 ◽  
Vol 81 (2) ◽  
pp. 215-217 ◽  
Author(s):  
G I Kaufman ◽  
G T DiFerdinando ◽  
S E Gottesman
2018 ◽  
Vol 19 (18) ◽  
pp. 1395-1401 ◽  
Author(s):  
Erik Hefti ◽  
David M Jacobs ◽  
Khyatiben Rana ◽  
Javier G Blanco

2019 ◽  
Vol 33 (9) ◽  
pp. 699-703
Author(s):  
Neel H. Patel ◽  
Suraj S. Parikh ◽  
Jonathan B. Bloom ◽  
Ariel Schulman ◽  
Jonathan Wagmaister ◽  
...  

2016 ◽  
Vol 10 (3) ◽  
pp. 210-215 ◽  
Author(s):  
John A. Buza ◽  
James X. Liu ◽  
Jeffrey Jancuska ◽  
Joseph A. Bosco

Background. Total ankle arthroplasty (TAA) provides an alternative to ankle fusion (AF). The purpose of this study is to (1) determine the extent of TAA regionalization, as well as examine the growth of TAA performed at high-, medium-, and low-volume New York State institutions and (2) compare this regionalization and growth with AF. Methods. The New York Statewide Planning and Research Cooperative System (SPARCS) administrative data were used to identify 737 primary TAA and 7453 AF from 2005 to 2014. The volume of TAA and AF surgery in New York State was mapped according to patient and hospital 3-digit zip code. Results. The number of TAA per year grew 1500% (from 11 to 177) from 2005 to 2014, while there was a 35.6% reduction (from 895 to 576) in yearly AF procedures. TAA recipients were widely distributed throughout the state, while TAA procedures were regionalized to a few select metropolitan centers. AF procedures were performed more uniformly than TAA. The number of TAA has continued to increase at high- (15 to 91) and medium-volume (14 to 67) institutions where it has decreased at low-volume institutions (44 to 19). Conclusion. The increased utilization of TAA is attributed to relatively few high-volume centers located in major metropolitan centers. Levels of Evidence: Level IV: well-designed case-control or cohort studies


1991 ◽  
Vol 81 (Suppl) ◽  
pp. 35-40 ◽  
Author(s):  
P F Smith ◽  
J Mikl ◽  
B I Truman ◽  
L Lessner ◽  
J S Lehman ◽  
...  

2011 ◽  
Vol 26 (2) ◽  
pp. 131-139 ◽  
Author(s):  
Daniel E. Gordon ◽  
Lusine R. Ghazaryan ◽  
Julia Maslak ◽  
Bridget J. Anderson ◽  
Kathleen S. Brousseau ◽  
...  

2021 ◽  
Vol 4 (2) ◽  
pp. e2037069
Author(s):  
James M. Tesoriero ◽  
Carol-Ann E. Swain ◽  
Jennifer L. Pierce ◽  
Lucila Zamboni ◽  
Meng Wu ◽  
...  

2012 ◽  
Vol 33 (7) ◽  
pp. 725-731 ◽  
Author(s):  
Amanda M. Farr ◽  
Brandon Aden ◽  
Don Weiss ◽  
Denis Nash ◽  
Melissa A. Marx

Objective.To describe trends in hospitalizations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in New York City over 10 years and to explore the demographics and comorbidities of patients hospitalized with CA-MRSA infections.Design.Retrospective analysis of hospital discharges from New York State's Statewide Planning and Research Cooperative System database from 1997 to 2006.Patients.All patients greater than 1 year of age admitted to New York hospitals with diagnosis codes indicating MRSA who met the criteria for CA-MRSA on the basis of admission information and comorbidities.Methods.We determined hospitalization rates and compared demographics and comorbidities of patients hospitalized with CA-MRSA versus those hospitalized with all other non-MRSA diagnoses by multivariable logistic regression.Results.Of 18,226 hospitalizations with an MRSA diagnosis over 10 years, 3,579 (20%) were classified as community-associated. The CA-MRSA hospitalization rate increased from 1.47 to 10.65 per 100,000 people overall from 1997 to 2006. Relative to non-MRSA hospitalizations, men, children, Bronx and Manhattan residents, the homeless, patients with human immunodeficiency virus (HIV) infection, and persons with diabetes had higher adjusted odds of CA-MRSA hospitalization.Conclusions.The CA-MRSA hospitalization rate appeared to increase between 1997 and 2006 in New York City, with residents of the Bronx and Manhattan, men, and persons with HIV infection or diabetes at increased odds of hospitalization with CA-MRSA. Further studies are needed to explore how changes in MRSA incidence, access to care, and other factors may have impacted these rates.


1994 ◽  
Vol 74 (2) ◽  
pp. 198-219 ◽  
Author(s):  
MALCOLM L. LACHANCE-McCULLOUGH ◽  
JAMES M. TESORIERO ◽  
MARTIN D. SORIN ◽  
ANDREW STERN

New York State's prison population has the highest seroprevalence of human immunodeficiency virus (HIV) among incarcerated populations in the United States. Five percent of the State prison inmate population is female. To date there have been few studies of incarcerated females in New York State (NYS). Seroprevalence rates have ranged from 18.9% to as high as 29%. In 1991, counselors from the New York State Department of Health (NYSDOH) AIDS Institute's Criminal Justice Initiative, in collaboration with the State's Department of Correctional Services (NYSDOCS), began to offer educational services and anonymous pretest counseling, HIV antibody testing, and posttest counseling to NYS female prisoners. With preliminary program testing data (N = 216) descriptive and multivariate techniques are used to evaluate the demographic and risk-related behaviors associated with HIV infection among female inmates in this voluntary HIV testing program. Results are discussed in light of previous research findings regarding the correlates of HIV seropositivity among New York State prison inmates and compared to previous blinded epidemiological studies of female inmates in the State. Future research, addressing the limitations of this preliminary study, is proposed.


Sign in / Sign up

Export Citation Format

Share Document